TY - JOUR
T1 - Oxoisoaporphines and aporphines
T2 - Versatile molecules with anticancer effects
AU - Rodríguez-Arce, Esteban
AU - Cancino, Patricio
AU - Arias-Calderón, Manuel
AU - Silva-Matus, Paul
AU - Saldías, Marianela
N1 - Funding Information:
This research and the APC was funded by CONICT+PAI/Convocatoria Nacional Subvencion a la Instalacion en la Academia (SIA), Convocatoria 2018. Grant number 77180052
Funding Information:
Funding: This research and the APC was funded by CONICT+PAI/Convocatoria Nacional Subvención a la Instalación en la Academia (SIA), Convocatoria 2018. Grant number 77180052.
Publisher Copyright:
© 2019 by the authors. Licensee MDPI, Basel, Switzerland.
PY - 2020/1/1
Y1 - 2020/1/1
N2 - Cancer is a disease that involves impaired genome stability with a high mortality index globally. Since its discovery, many have searched for effective treatment, assessing different molecules for their anticancer activity. One of the most studied sources for anticancer therapy is natural compounds and their derivates, like alkaloids, which are organic molecules containing nitrogen atoms in their structure. Among them, oxoisoaporphine and sampangine compounds are receiving increased attention due to their potential anticancer effects. Boldine has also been tested as an anticancer molecule. Boldine is the primary alkaloid extract from boldo, an endemic tree in Chile. These compounds and their derivatives have unique structural properties that potentially have an anticancer mechanism. Different studies showed that this molecule can target cancer cells through several mechanisms, including reactive oxygen species generation, DNA binding, and telomerase enzyme inhibition. In this review, we summarize the state-of-art research related to oxoisoaporphine, sampangine, and boldine, with emphasis on their structural characteristics and the relationship between structure, activity, methods of extraction or synthesis, and anticancer mechanism. With an effective cancer therapy still lacking, these three compounds are good candidates for new anticancer research.
AB - Cancer is a disease that involves impaired genome stability with a high mortality index globally. Since its discovery, many have searched for effective treatment, assessing different molecules for their anticancer activity. One of the most studied sources for anticancer therapy is natural compounds and their derivates, like alkaloids, which are organic molecules containing nitrogen atoms in their structure. Among them, oxoisoaporphine and sampangine compounds are receiving increased attention due to their potential anticancer effects. Boldine has also been tested as an anticancer molecule. Boldine is the primary alkaloid extract from boldo, an endemic tree in Chile. These compounds and their derivatives have unique structural properties that potentially have an anticancer mechanism. Different studies showed that this molecule can target cancer cells through several mechanisms, including reactive oxygen species generation, DNA binding, and telomerase enzyme inhibition. In this review, we summarize the state-of-art research related to oxoisoaporphine, sampangine, and boldine, with emphasis on their structural characteristics and the relationship between structure, activity, methods of extraction or synthesis, and anticancer mechanism. With an effective cancer therapy still lacking, these three compounds are good candidates for new anticancer research.
KW - Alkaloids
KW - Anticancer action
KW - Aporphine
KW - Boldine
KW - Oxoisoaporphine
KW - ROS
KW - Sampangine
KW - Structure-biological activity
KW - Telomerase inhibition
UR - http://www.scopus.com/inward/record.url?scp=85077454662&partnerID=8YFLogxK
U2 - 10.3390/molecules25010108
DO - 10.3390/molecules25010108
M3 - Review article
C2 - 31892146
AN - SCOPUS:85077454662
SN - 1420-3049
VL - 25
JO - Molecules
JF - Molecules
IS - 1
M1 - 108
ER -